Build a medical device that works & sells. We get you there.
Where We Shine
Eliomedica, a medical device innovation firm, bridges the gaps between regulatory, business, and development strategies to ensure seamless commercialization. Our integrated approach empowers startups to:
• Create Products with Value
• Accelerate Market Entry
• Attract Investment
Our Top-notch Projects
- At-home, Point-of-Care, In Vitro Diagnostics
- Medical Robotics
- AI Image Analysis & SaMD
- Remote Patient Monitoring (RPM)
- Vascular Embolization Devices
- Pharmacogenetic Testing (PGx)
- Disinfection & Sterilization Devices
- Combination Products
Regulatory Affairs
Research & Development
Go-to-Market Strategy
- Strategy and roadmapping
- Pre-submissions and submissions
- FDA communications
- Design History Files (DHF)
Go-to-Market Strategy
Research & Development
Go-to-Market Strategy
- Market landscape analysis
- Value proposition development
- Validation and sales strategy
- Product-market fit strategy
Research & Development
Research & Development
Research & Development
- Pre-clinical and clinical strategies
- Development roadmapping
- Performance testing strategy
- Systems engineering
We are Driven by the Uniqueness of Every Founder
We solve medical technology challenges at the intersection of science, engineering, regulatory, and go-to-market strategy. Our expertise and passion span novel devices, deep tech, and combination products. By combining know-how, first-principles thinking, and a cofounder mindset, we navigate commercialization paths alongside founders.
- Early stage to VC-backed startups
- Spin-offs from large organizations
- Physician entrepreneurs
- MedTech investment firms
- Hospital innovation hubs
Partners
Arash Samimi, PhD
Petter Hansson, MBA
Petter Hansson, MBA
Founding Managing Partner
Regulatory Affairs & R&D Strategy
Highlights:
Regulatory Advisor, EEE Corp Group
Business Dev, StarFish Medical
Systems Eng, Synaptive Medical
Petter Hansson, MBA
Petter Hansson, MBA
Petter Hansson, MBA
Partner
Commercialization & Business Strategy
Highlights:
General Manager, Germiphene
General Manager & VP Ops, Levo Medical
Director Service Sales & Marketing, Philips
Parth Agarwal, MBA
Petter Hansson, MBA
Parth Agarwal, MBA
Partner
Sales & Go-to-Market Strategy
Highlights:
Business Dev & Investor, MediPines
Business Dev & investor, Pramptex
HW/SW Engineer, VIAVI Solutions
Lead Consultants & Advisors
Golnaz Moeini, RAC
Golnaz Moeini, RAC
Golnaz Moeini, RAC
Sr Consultant
Regulatory Strategy
Highlights:
Founder, MedEdge Regulatory
Director at Arterys, RA at Stryker
T. David Pyron
Golnaz Moeini, RAC
Golnaz Moeini, RAC
Sr Consultant
Product Development Strategy
Highlights:
Program Mgr, StarFish Medical
Director, Major manufacturing
Brent Bailey, PhD
Golnaz Moeini, RAC
Francis Jeanson, PhD
Sr Consultant
Systems Engineering & Robotics
Highlights:
Systems Designer, StarFish Medical
Systems Designer, Synaptive Medical
Francis Jeanson, PhD
Francis Jeanson, PhD
Francis Jeanson, PhD
Advisor
Health Data & AI Strategy
Highlights:
Head, Ontario Brain Institute
Director, UHN
Golddy Kaur
Francis Jeanson, PhD
Golddy Kaur
Advisor
Regulatory & Business Strategy
Highlights:
SVP, Profound Medical
Founder, MRS and Wisdom Waves
Emily Hayhurst, MDes
Aanshi Gandhi, PhD Candidate
Aanshi Gandhi, PhD Candidate
2024-2025
Strategist, Design & Communications
Emily brought together human factors engineering and regulatory perspectives to help design products that are safe, effective, and solve real problems. During her time at Eliomedica, she gained hands-on experience supporting FDA pre-submissions and managed the end-to-end delivery of client projects.
Aanshi Gandhi, PhD Candidate
Aanshi Gandhi, PhD Candidate
Aanshi Gandhi, PhD Candidate
2025 - present
Scientific Consultant
Aanshi's background combines biomedical engineering and synthetic biology. Her PhD research focuses on transplantation of stem cell–derived cardiomyocytes. At Eliomedica, she works to bridge biologics and medical devices, supporting deep tech startups in advancing the commercialization of combination products.
Through the Eyes of our Clients
Eliomedica has been a trusted partner in shaping Unephra’s regulatory strategy for our in-vitro diagnostic device. Their team provided expert guidance on classification, regulatory pathway, and testing strategy for our at-home IVD and successfully guided us through our FDA pre-submission. We highly recommend Eliomedica to any medical device startup seeking exceptional regulatory support.
Farhad Taghibakhsh, PhD
Founder & CEO, Unephra
---
Eliomedica's expertise in regulatory and pre-clinical strategy was invaluable for our MedTech startup, providing the clarity and direction needed to navigate complex compliance landscapes. Their insights significantly enhanced our value proposition, setting a solid foundation for our product development and market entry.
Dr. Anya McLaren-Barnett, MD
Founder, The Sleep Health Organization
---
ElioMedica has been an invaluable partner for NovaTechs, offering exceptional regulatory consulting with a unique blend of expertise, deep knowledge, and an innovative approach. Their method not only supports startups like ours in navigating complex regulatory landscapes but also empowers us to learn and implement regulatory practices effectively. I genuinely look forward to our meetings with ElioMedica - a rare sentiment for regulatory discussions - because of the passion and insight they bring to the table. Each interaction is an opportunity to grow, and their dedication to fostering understanding makes the process both engaging and educational. I wholeheartedly recommend ElioMedica to anyone seeking a partner who combines technical excellence with a collaborative and inspiring approach.
Mohammad Nasiri, PhD
Founder & CEO, NovaTechs
---
We partnered with Eliomedica to collaboratively lay the foundation for a holistic commercialization strategy. The outcome supports our internal alignment and investor communications. Their first-principles and adaptable approach makes them a valuable partner in our journey towards market fit and growth. We found Eliomedica committed to long-term relationships and look forward to ongoing collaboration with them.
Dr Robert Arntfield, MD
Founder & CEO, Deep Breathe AI
Our Trusted Partner
Through our trusted partner, DigiDaaS, we provide dedicated innovation and strategic support to our US-based clients.